Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China

DNA and Cell Biology

Volumn 32, Issue 5, 2013, Pages 268-273

  Yuan, Fang ^a   Zhang, Lu Shun ^b   Li, Hong Yu ^c   Liao, Miao ^a   Lv, Meili ^a   Zhang, Chongjie ^a  

^a SICHUAN UNIVERSITY   (China)

^b Cheng du Medical College   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CHINA; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN TISSUE; INTRON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84877591706     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1910     Document Type: Article

References (46)

1. Alvarez, R., Alvarez, V., Lahoz, C.H., Martinez, C., Pena, J., Sanchez, J.M., et al. (1999). Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 67, 733-736.
2. Bredt, D.S. (1999). Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31, 577-596.
3. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.P., Arveiler, D., et al. (1992). Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641-644.
4. Carl-McGrath, S., Ebert, M.P., Lendeckel, U., and Rocken, C. (2007). Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. Cancer Biol Ther 6, 1218-1226.
5. Casas, J.P., Bautista, L.E., Humphries, S.E., and Hingorani, A.D. (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109, 1359-1365.
6. Celentano, A., Mancini, F.P., Crivaro, M., Palmieri, V., Ferrara, L.A., De Stefano, V., et al. (1999). Cardiovascular risk factors, angiotensin- converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol 83, 1196-1200.
7. Conde, M.C., Ramirez-Lorca, R., Lopez-Jamar, J.M., Molero, E., Ramirez-Armengol, J.A., Moreno Nogueira, J.A., et al. (2006). Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep 16, 353-359.
8. Crawford, F., Abdullah, L., Schinka, J., Suo, Z., Gold, M., Duara, R., et al. (2000). Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 280, 215-219.
9. Deshayes, F., and Nahmias, C. (2005). Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 16, 293-299.
10. El-Serag, H.B., and Rudolph, K.L. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576.
11. Farrer, L.A., Sherbatich, T., Keryanov, S.A., Korovaitseva, G.I., Rogaeva, E.A., Petruk, S., et al. (2000). Association between angiotensin-converting enzyme and Alzheimer disease. Arch Neurol 57, 210-214.
12. Fatini, C., Gensini, F., Sticchi, E., Battaglini, B., Prisco, D., Fedi, S., et al. (2003). ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 33, 642-647.
13. Gardemann, A., Fink, M., Stricker, J., Nguyen, Q.D., Humme, J., Katz, N., et al. (1998). ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 139, 153-159.
14. Gomaa, A.I., Khan, S.A., Toledano, M.B., Waked, I., and Taylor-Robinson, S.D. (2008). Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14, 4300-4308.
15. Grande, M., Carlstrom, K., Stege, R., Pousette, A., and Faxen, M. (2000). Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells. Prostate 45, 232-237.
16. Haswell-Elkins, M.R., Satarug, S., Tsuda, M., Mairiang, E., Esumi, H., Sithithaworn, P., et al. (1994). Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis. Mutat Res 305, 241-252.
17. Hefler, L.A., Grimm, C., Lantzsch, T., Lampe, D., Koelbl, H., Lebrecht, A., et al. (2006). Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat 98, 151-155.
18. Hu, J., Miyatake, F., Aizu, Y., Nakagawa, H., Nakamura, S., Tamaoka, A., et al. (1999). Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci Lett 277, 65-67.
19. Lu, J., Wei, Q., Bondy, M.L., Yu, T.K., Li, D., Brewster, A., et al. (2006). Promoter polymorphism (-786t > C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 107, 2245-2253.
20. Medeiros, R., Morais, A., Vasconcelos, A., Costa, S., Pinto, D., Oliveira, J., et al. (2002). Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 11, 343-350.
21. Medeiros, R., Vasconcelos, A., Costa, S., Pinto, D., Lobo, F., Morais, A., et al. (2004). Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202, 330-335.
22. Mirvish, S.S. (1995). Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93, 17-48.
23. Miyahara, K., Kawamoto, T., Sase, K., Yui, Y., Toda, K., Yang, L.X., et al. (1994). Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem 223, 719-726.
24. Murphey, L.J., Gainer, J.V., Vaughan, D.E., and Brown, N.J. (2000). Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 102, 829-832.
25. Nadaud, S., Bonnardeaux, A., Lathrop, M., and Soubrier, F. (1994). Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 198, 1027-1033.
26. Narain, Y., Yip, A., Murphy, T., Brayne, C., Easton, D., Evans, J.G., et al. (2000). The ACE gene and Alzheimer's disease susceptibility. J Med Genet 37, 695-697.
27. Neugebauer, S., Baba, T., and Watanabe, T. (2000). Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49, 500-503.
28. O'Donnell, C.J., Lindpaintner, K., Larson, M.G., Rao, V.S., Ordovas, J.M., Schaefer, E.J., et al. (1998). Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97, 1766-1772.
29. Perry, R.T., Collins, J.S., Harrell, L.E., Acton, R.T., and Go, R.C. (2001). Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 105, 332-342.
30. Rao, S., Austin, H., Davidoff, M.N., and Zafari, A.M. (2005). Endothelial nitric oxide synthase intron 4 polymorphism is a marker for coronary artery disease in African-American and Caucasian men. Ethn Dis 15, 191-197.
31. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 1343-1346.
32. Rigat, B., Hubert, C., Corvol, P., and Soubrier, F. (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20, 1433.
33. Rocken, C., Lendeckel, U., Dierkes, J., Westphal, S., Carl-McGrath, S., Peters, B., et al. (2005). The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 11, 2526-2530.
34. Soda, S., Suzuki, K., and Aizawa, Y. (2005). [Polymorphisms in ACE gene deletion/insertion in type 2 diabetes]. Nihon Rinsho 63 Suppl 2, 198-201.
35. Sugimoto, M., Furuta, T., Shirai, N., Ikuma, M., Sugimura, H., and Hishida, A. (2006). Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 15, 1929-1934.
36. Sumbul, A.T., Akkiz, H., Bayram, S., Bekar, A., Akgollu, E., and Sandikci, M. (2012). p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep 39, 1639-1647.
37. Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., and Egido, J. (2003). Inflammation and angiotensin II. Int J Biochem Cell Biol 35, 881-900.
38. Tang, Z.Y. (2001). Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 7, 445-454.
39. Wang, Y., Kikuchi, S., Suzuki, H., Nagase, S., and Koyama, A. (1999). Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in nondiabetic renal diseases. Nephrol Dial Transplant 14, 2898-2902.
40. Wink, D.A., Hanbauer, I., Grisham, M.B., Laval, F., Nims, R.W., Laval, J., et al. (1996). Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Current Top Cell Regul 34, 159-187.
41. Xu, W., Liu, L.Z., Loizidou, M., Ahmed, M., and Charles, I.G. (2002). The role of nitric oxide in cancer. Cell Res 12, 311-320.
42. Yaren, A., Turgut, S., Kursunluoglu, R., Oztop, I., Turgut, G., Kelten, C., et al. (2006). Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J Exp Med 210, 109-116.
43. Yeh, C.C., Santella, R.M., Hsieh, L.L., Sung, F.C., and Tang, R. (2009). An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer J 124, 1565-1571.
44. Yilmaz, E., Mir, S., and Berdeli, A. (2009). Endothelial nitric oxide synthase (eNOS) gene polymorphism in early term chronic allograft nephropathy. Transplant Proc 41, 4361-4365.
45. Yoshiji, H., Kuriyama, S., and Fukui, H. (2002). Angiotensin-Iconverting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 23, 348-356.
46. Zintzaras, E., Raman, G., Kitsios,G., and Lau, J. (2008). Angiotensinconverting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 168, 1077-1089.